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ABSTRACT: Extracellular matrix contains various signals for
cell surface receptors that regulate cell fate through modulation
of cellular activities such as proliferation and differentiation.
Cues from extracellular matrix components can be used for
development of new materials to control the stem cell fate. In
this study, we achieved control of stem cell fate toward
osteogenic commitment by using a single extracellular matrix
element despite the contradictory effect of mechanical
stiffness. For this purpose, we mimicked bone extracellular
matrix by incorporating functional sequence of fibronectin
type III domain from native tenascin-C on self-assembled peptide nanofibers. When rat mesenchymal stem cells (rMSCs) were
cultured on these peptide nanofibers, alkaline phosphatase (ALP) activity and alizarin red staining indicated osteogenic
differentiation even in the absence of osteogenic supplements. Moreover, expression levels of osteogenic marker genes were
significantly enhanced revealed by quantitative real-time polymerase chain reaction (qRT-PCR), which showed the remarkable
bioactive role of this nanofiber system on osteogenic differentiation. Overall, these results showed that tenascin-C mimetic
peptides significantly enhanced the attachment, proliferation, and osteogenic differentiation of rMSCs even in the absence of any
external bioactive factors and regardless of the suitable stiff mechanical properties normally required for osteogenic
differentiation. Thus, these peptide nanofibers provide a promising new platform for bone regeneration.
1. INTRODUCTION
Recent advances in stem cell biology have shown that
mesenchymal stem cells (MSCs) are pluripotent progenitor
cells with the ability to differentiate into cartilage, bone, muscle,
tendon, ligament, and fat cells, and they play important roles in
the repair of bone defects.1,2 Differentiation of MSCs into
specific and distinct phenotypes involves certain cellular
transitions.2 The differentiation of MSCs in vitro largely
depends on the culture conditions. The interaction of external
factors, such as nutrients, structural characteristics, and
bioactivity of the environment, with internal factors (genetic
and epigenetic characteristics)3 is important for the transition
from one differentiation stage to another. Osteogenic differ-
entiation of MSCs in vitro is mostly induced by the presence of
osteogenic supplements including dexamethasone, ascorbic
acid, and β-glycerol phosphate.4 Surface structure is also
important for the behavior of the cells,5 and it directly affects
the cell response6−8 and new tissue formation process.3,5 Cell
fate can be manipulated through altering the rigidity of the
substrate, and it was reported that osteogenic differentiation of
MSCs was maximized on matrices with moduli between 10 and
40 kPa,9−11 which emphasizes the role of physical character-
istics of the matrix as regulators of stem cell behavior to guide
tissue development.
The components of the extracellular matrix are important for
the regulation of cell behavior during tissue development and
pathology, as well as for the maintenance of normal function.
ECM not only acts as a scaffold for the cells; but it also
functions as a store of growth factors and cytokines.40 In bone,
a large number of ECM components including collagens,
proteoglycans and glycoproteins contribute to the structure of
bone.12,13 Tenascin is an extracellular matrix glycoprotein,
which is also known as cytotactin or hexabrachion. The
tenascin (TN) family of glycoproteins (TN-C, TN-R, TN-W,
TN-X, and TN-Y) show highly dynamic patterns of expression
in the embryo, especially during neural development, skeleto-
genesis, and vasculogenesis. They are also expressed in adults
during processes including wound healing, nerve regeneration,
and tissue involution, and in pathogenesis such as vascular
disease, tumorigenesis, and metastasis.14 Within this family,
TN-C is a hexamer of disulfide-linked subunits. Each subunit is
composed of several domains of repeated structural units,
which include epidermal growth factor-like repeats and
fibronectin type III (FNIII) repeats.15 TN-C interacts with a
variety of ECM molecules such as fibronectin, as well as cell
surface molecules including integrins, contactin/F11, annexin
II, and heparan sulfated proteoglycans, and acts as a regulator of
cell behavior including adhesion, spreading and proliferation.16
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TN-C is found in the condensing mesenchyme of developing
bones, which is the primary center of ossification, and the
periosteal and endosteal surfaces of mineralized bone.17,18 Since
TN-C is found in the matrix on bone surfaces and is mostly
absent in the connective tissues surrounding bone, this protein
is thought to be important in the regulation of osteoblast or
osteoclast function.19 It was previously shown that exogenous
TN-C is able to affect the morphology and differentiation of
osteoblast-like cells and that endogenous TN-C plays an
important role in the maintenance of the morphology,
differentiation, and proliferation in these cells.19 In another
study, a short linear amino acid sequence derived from human
TN-C, VFDNFVLK, is necessary and sufficient to maintain the
function of full sequence TN-C for the formation of the neurite
outgrowth.20
The ability of self-assembled peptide amphiphile (PA)
nanofibers to mimic natural ECM renders them attractive for
regenerative medicine applications. PA nanofibers can be
modified to meet the needs of a variety of tissues by varying
the functional peptide sequences. Hydrophobic collapse of alkyl
tails and β-sheet formation between PA molecules result in
formation of nanofibers in aqueous solution, where short
biofunctional amino acid sequences can be presented on the
surface of these nanofibers.21 The supramolecular architecture
of PA nanofibers enable ease of using a combination of several
bioactive sequences for manipulating the cells in terms of
adhesion, proliferation, and differentiation.22−28 For instance, a
combination of bioactive sequences inspired by ECM proteins
was used to control cell behavior for biomineralization and
bone regeneration when supplemented with osteogenic culture
media.23
A tenascin-C derived peptide sequence (VFDNFVLKK) was
previously shown to sufficiently maintain the function of full
length TN-C protein in inducing neurite outgrowth. In the
present study, we investigated whether the same sequence is
also capable of inducing osteogenic differentiation based on the
fact that tenascin-C is a common protein in ECM of both
neural and bone tissue. Overall, we showed that tenascin-C
mimetic self-assembled peptide nanofibers significantly en-
hanced the attachment, proliferation, and osteogenic differ-
entiation of rMSCs even in the absence of any external
bioactive factors and regardless of the suitable mechanical
properties normally required for osteogenic differentiation.
Since mechanical cues and external osteogenic supplements are
known to be important requirements for osteogenic commit-
ment of MSCs, this study presents a striking example for the
ability of a single biological cue to override these requirements
and makes TN-C mimetic peptide nanofibers a promising new
platform for bone regeneration.
2. EXPERIMENTAL SECTION
2.1. Materials. All protected amino acids, lauric acid, 4-(2′,4′-
dimethoxyphenyl-Fmoc-aminomethyl)-phenoxyacetamido-norleucyl-
MBHA resin (Rink amide MBHA resin), 2-(1H-benzotriazol-1-yl)-
1,1,3,3-tetramethyluroniumhexafluorophosphate (HBTU), and diiso-
propylethylamine (DIEA) were purchased from Nova-Biochem,
ABCR, or Sigma-Aldrich. Calcein-AM and other cell culture materials
were purchased from Invitrogen. All other chemicals and materials
used in this study were purchased from Thermo Scientific or Sigma-
Aldrich.
2.2. Synthesis of Peptide Amphiphile (PA) Molecules. Peptide
amphiphile molecules were synthesized on Rink amide MBHA resin or
Fmoc-Glu(OtBu)-Wang resin using the Fmoc-protected solid phase
peptide synthesis method. Amino acid couplings were performed with
2 equiv of amino acids activated with 1.95 equiv of HBTU and 3 equiv
of DIEA for 2 h. Fmoc removal was performed with 20% piperidine/
dimethylformamide (DMF) solution for 20 min. Acetic anhydride
(10%)/DMF solution was used to permanently acetylate the
unreacted amine groups after each coupling step. DMF and
dichloromethane (DCM) were used as washing solvents after each
step. Cleavage of the PAs and protection groups from the resin was
carried out with a mixture of TFA/TIS/H2O in the ratio of 95:2.5:2.5
for 3 h. Excess TFA removal was carried out by rotary evaporation.
PAs in the remaining solution were precipitated in ice-cold diethyl
ether overnight. The precipitate was collected by centrifugation next
day and dissolved in ultrapure water. This solution was frozen at −80
°C for 4 h and then lyophilized for 4−5 days. PAs were characterized
by liquid chromatography−mass spectrometry (LC−MS) (Figure S1,
Supporting Information). Mass spectrum was obtained with Agilent
LC-MS equipped with Agilent 6530 Q-TOF with an ESI source and
Zorbax Extend-C18 2.1 mm × 50 mm column for basic conditions and
Zorbax SB-C8 4.6 mm × 100 mm column for acidic conditions. A
gradient of (a) water (0.1% formic acid or 0.1% NH4OH) and (b)
acetonitrile (0.1% formic acid or 0.1% NH4OH) was used. In order to
remove residual TFA, positively charged peptide amphiphiles were
treated with 0.1 M HCl solution and lyophilized. To purify the
peptides, an Agilent preparative reverse-phase HPLC system equipped
with a Zorbax Extend-C18 21.2 mm × 150 mm column was used for
basic conditions, and a Zorbax SB-C8 21.2 mm × 150 mm column was
used for acidic conditions. A gradient of (a) water (0.1% TFA or 0.1%
NH4OH) and (b) acetonitrile (0.1% TFA or 0.1% NH4OH) was used.
All peptide batches were freeze-dried and reconstituted in ultrapure
water at pH 7.4 before use.
2.3. Scanning Electron Microscope (SEM) Imaging of PA
Nanofiber Network. PA nanofiber networks were observed by
imaging with SEM. Negatively and positively charged PA solutions (8
mM) were mixed at 2:1 volume ratio (final volume being 50 μL) to
produce gels with neutral charge. Gels were formed on silicon wafer
and dehydrated by transferring to 20%, 40%, 60%, 80%, and 100% v/v
ethanol sequentially. They were critical point-dried by using
Autosamdri 815B equipment from Tousimis. Dried PA gels were
coated with 4 nm Au/Pd, and SEM (FEI Quanta 200 FEG) images
were taken using an Everhart−Thornley detector (ETD) at high
vacuum mode at 5 keV beam energy.
2.4. Scanning Transmission Electron Microscope (STEM)
Imaging of PA Nanofiber Matrices. Samples for TEM imaging
were prepared by mixing 2 mM TC-PA or 2 mM K-PA and 1 mM E-
PA in equal volumes and then diluting sample 10 times and placing
them on a 200-mesh carbon TEM grid for 10 min followed by 2 wt %
uranyl acetate staining for 2 min and drying. STEM images at HAADF
mode were acquired with FEI Tecnai G2 F30 TEM at 300 kV.
2.5. Circular Dichroism. A JASCO J815 CD spectrometer was
used at room temperature. Negatively and positively charged 2.5 ×
10−4 M PA solutions were mixed at 2:1 volume ratio (final volume
being 500 μL) to produce nanofibers with net neutral charge.
Measurements were carried out from 300 to 190 nm data interval, data
pitch being 0.1 nm, and scanning speed being 100 nm min−1, all
measurements with three accumulations. Digital Integration Time
(DIT) was selected as 1 s, bandwidth as 1 nm, and the sensitivity was
standard.
2.6. Oscillatory Rheology. Oscillatory rheology measurements
were performed with Anton Paar Physica RM301 rheometer operated
with a 25 mm parallel plate configuration at 25 °C. Total volume of
250 μL with 8 mM concentrations of each PA component was
carefully loaded onto the center of the lower plate and incubated for
10 min for gelation before measurement. After equilibration, the upper
plate was lowered to a gap distance of 0.5 mm. Storage moduli (G′)
and loss moduli (G″) values were scanned from 100 to 0.1 rad s−1 of
angular frequency, with a 0.5% shear strain. Three samples were
measured for each PA gel.
2.7. Cell Culture and Maintenance. Rat mesenchymal stem cells
(rMSCs, Invitrogen, passage number 7) were used in all cell culture
experiments including viability, proliferation, gene expression analysis,
ALP activity, and calcium deposition. Cells were cultured in 75 cm2
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flasks at a density of 2 × 103 cells/cm2 at 37 °C in a humidified
incubator and supplied with 5% CO2. Cells were maintained in
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with
10% fetal bovine serum (FBS), 1% penicillin/streptomycin, and 2 mM
L-glutamine. All cell culture experiments were carried out after
reaching 90% confluency. The culture medium was changed every 3−4
days. Cells were seeded with the same medium content. The day after
seeding cells, cell medium was replaced with minimum essential
medium (MEM) with 3% FBS, 1% penicillin/streptomycin, and 2 mM
L-glutamine. For alizarin red staining, this medium was also
supplemented with 10 mM β-glycerophosphate, differently from the
other experiments. Medium was changed every 3 days.
2.8. Viability Assay. To form TC-PA/E-PA or K-PA/E-PA gel,
equal volumes of 3 mM TC-PA or K-PA and 1.5 mM E-PA were used
in order to neutralize the charges. PA-gel coated plates were incubated
at 37 °C for 30 min, prior to overnight incubation in a laminar flow
hood at room temperature for solvent evaporation. The next day, PA
matrix formed on the plates was UV sterilized. By addition of cells in
culture media to PA-coated surfaces, rehydration of the PA matrix
formed a thin-gel on the surface. The viability tests of mesenchymal
stem cells were performed at predetermined time intervals (24, 48, 72
h) by calcein-AM and ethidium homodimer 1 (EthD-1) staining and
Alamar blue assay. Cells were incubated on PA-coated and uncoated
tissue culture plates at a density of 2 × 103 cells/cm2. After 24, 48, and
72 h of incubation, cell medium was discarded; cells were washed with
PBS and then incubated with 2 μM calcein-AM and 2 μM EthD-1 in
PBS for 30 min at room temperature. Finally, five random images were
taken at 10× magnification from each well for both qualitative and
quantitative analysis by using a fluorescence microscope. Cells were
counted with NIH ImageJ software for proliferation. For Alamar blue
assay, medium was discarded after 24, 48, and 72 h of incubation and
replaced with medium containing 10% Alamar blue. Blank group
contained only Alamar blue medium without cells. After 4 h incubation
at 37 °C, absorbance measurement was performed by Spectramax M5
microplate reader at 570 and 600 nm as reference.
2.9. SEM Imaging of Mesenchymal Stem Cells on PA
Nanofiber-Coated Surfaces. The morphology and spreading of
mesenchymal stem cells were examined by SEM imaging by using an
ETD detector at high vacuum mode at 5 keV beam energy. For this
purpose, glass coverslips were coated with PAs, and cells were seeded
on top of the coated and uncoated surfaces at a density of 2 × 103
cells/cm2. Seven and twelve days after incubation, cells were rinsed
with PBS and fixed with 2% gluteraldehyde/PBS and 1 wt % OsO4 for
1 h each, respectively. Fixed cells were washed with water and then
dehydrated sequentially in 20%, 40%, 60%, 80%, and 100% ethanol.
Samples were critical point dried with Autosamdri-815B Tousimis and
coated with 6 nm Au−Pd before imaging.
2.10. Gene Expression Analysis. Gene expression profiles for
differentiation were assessed by quantitative RT-PCR analysis. rMSCs
were seeded at a density of 2 × 103 cells/cm2 on peptide nanofiber
coated surfaces and bare surface, and after 12 days of incubation of the
cells on PA-coated surfaces and TCP, RNA was isolated using TRIzol
(Invitrogen) according to manufacturer’s instructions. Yield and purity
of extracted RNA were assessed by Nanodrop 2000 (Thermo
Scientific). Primer sequences were designed using NCBI database
(Table S1, Supporting Information). cDNA synthesis from RNA and
qRT-PCR were performed using SuperScript III Platinum SYBR
Green one-step qRT-PCR kit according to manufacturer’s instructions.
Reaction conditions were briefly as follows: 55 °C for 5 min, 95 °C for
5 min, 40 cycles of 95 °C for 15 s, X °C for 30 s (varies according to
primer sets), and 40 °C for 1 min, followed by a melting curve analysis
to confirm product specificity. The reaction efficiencies for each primer
Figure 1. Self-assembled peptide amphiphile nanofibers. Chemical structures of TC-PA, E-PA, and K-PA are given. All PA molecules had a
hydrophobic alkyl tail consisting of lauric acid. While TC-PA had bioactive sequence, VFDNFVLK, epitope free PA molecules carried a β-sheet
forming peptide sequence, VVAG. This sequence consists of four nonpolar amino acid residues, among which valine has a very high β sheet-forming
propensity provided by its hydrophobic side chain, while glycine is used as a spacer between the hydrophobic part of the sequence and hydrophilic
epitope region.38,39
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set were evaluated by plotting a standard curve using 5-fold serial
dilutions of total RNA. For analysis of the expression data, primary
gene expression data was normalized by the expression level of
GAPDH. A comparative Ct method (Pfaffl method) was used to
analyze results.
2.11. Alkaline Phosphatase (ALP) Activity Assay. ALP activity
of rMSCs was analyzed by measuring the colorimetric product of p-
nitrophenol from endogenous ALP reaction after 3 and 7 days of
culture in differentiation medium. Cells (3 ×103 cm−2) were seeded on
PA-coated and uncoated TCP surfaces. Medium change was done
every 3 days. At predetermined time points, cells were rinsed with
PBS, and protein extraction was performed by using M-PER protein
extraction kit (Thermo)/5% protease inhibitor solution as 150 μL/
well for 30 min on shaker. After centrifugation of samples at 14000g
for 10 min at 4 °C, supernatants that contain proteins were taken, and
BCA protein assay was performed to quantify protein amount as
described in manufacturer’s protocol. Absorbance was determined at
562 nm by using a microplate reader. For ALP activity, 50 μL of
protein sample was incubated with 150 μL of p-nitrophenol phosphate
substrate in 96-well plates for 30 min on shaker. Serial dilutions of p-
nitrophenol in 0.25 M NaOH were used as standards. Finally, optical
density was determined at 405 nm by using Spectramax M5 microplate
reader. ALP results were normalized to total protein amount.
2.12. Imaging Mineral Deposition by Alizarin Red Staining.
The ability of mineralized nodule formation and calcium deposition of
MSCs on PA nanofiber-coated and uncoated tissue culture plates were
assessed by using alizarin red-S staining as described previously.29 In
brief, cells were incubated for 7 and 12 days at the densities of 4 × 103
cells/cm2. Cells were washed with PBS and fixed with ice-cold ethanol
for 1 h at room temperature. Then, fixed cells were washed with
distilled water and stained with 40 mM alizarin red-S solution (pH
4.2) for 30 min at room temperature on shaker. After washing 4−5
times with distilled water to get rid of nonspecific binding, PBS was
added and the calcium nodules were imaged under a microscope. For
quantification of calcium amount, PBS was discarded and 10%
cetylpyridinium chloride was added and incubated for 30 min at room
temperature. At the end of incubation, solution was transferred to 96-
well plate and absorbance measurement was done at 562 nm.
Cetylpyridinium chloride was used to release the remaining calcium-
bound alizarin red S.
2.13. Statistical Analysis. All quantitative values are presented as
mean ± SEM (standard error of means), and all the groups in
Figure 2. SEM images of TC-PA/E-PA (a) and K-PA/E-PA (b) gels reveal the ECM-like morphology of PA scaffolds. Scale bars are 5 μm in length.
STEM images of the TC-PA/E-PA and K-PA/E-PA nanofibers formed at pH 7.4 are given in panels c and d, respectively. Scale bars are 100 nm in
length. Characterization of secondary structure of peptide nanostructures by circular dichroism is given in panel f. Both PA combinations were found
to have β-sheet secondary structure by circular dichroism analysis. Mechanical properties of PA gels are given in panel g. Rheology results showed
gelation as a result of nanofibrous network formation by TC-PA/E-PA and K-PA/E-PA at pH 7.4.
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experiments were performed with at least three replicates. Two-way
analysis of variance (ANOVA) was used for statistical analysis, and p-
value of less than 0.05 was considered statistically significant.
3. RESULTS AND DISCUSSION
3.1. Characterization of Peptide Amphiphile Nano-
fibers. In this study, osteogenic scaffolds were generated
through self-assembly of peptide amphiphile molecules that
carry natural extracellular matrix protein tenascin-C (TN-C)
derived epitope (lauryl-VFDNFVLKK-Am (TC-PA)).20 The
control nanofibers did not display this epitope ((lauryl-
VVAGE-OH (E-PA) and lauryl-VVAGK-Am (K-PA)) (Figure
1a−c). TC-PA molecules formed nanofibers through self-
assembly when mixed with oppositely charged E-PA due to
electrostatic interactions, hydrophobic collapse, and β-sheet
driving units at physiological pH.30 Positively charged K-PA
and negatively charged E-PA molecules were mixed to induce
formation of nanofibers as an epitope-free control. STEM
imaging showed that both TC-PA/E-PA and K-PA/E-PA
nanofibers were uniform in diameter (10−20 nm) and several
micrometers in length (Figure 2c,d). These nanofibers formed
bundles that formed nanofiber networks that can encapsulate
water to form hydrogels. These nanofiber networks resembled
the nanofibrous structure of natural ECM at physiological pH
as evidenced by SEM imaging (Figure 2a,b). The secondary
structures of the tenascin-C mimetic and control nanofibers
were characterized using circular dichroism (CD) spectroscopy.
Both nanofiber types demonstrated predominantly β-sheet
structure with a chiral absorbance maximum at around 200 nm
and minimum at around 220 nm (Figure 2f).
Physical characteristics of the matrix are known to be a
potent cue for stem cell differentiation. Mechanical properties
of the gels were compared by using frequency sweep rheology
measurements at constant strain. Each gel (TC-PA/E-PA gel
and K-PA/E-PA gel) had higher storage modulus (G′) than loss
modulus (G″), indicating gel formation at physiological pH
(Figure 2g). The elastic modulus of TN-C mimetic PA scaffold
is around 270 Pa, which is lower than the elasticity of hard
matrices used to induce osteogenic differentiation in vitro9−11
and relatively lower than the elasticity modulus of epitope-free
control scaffold, which was around 1000 Pa.
3.2. PA Nanofibers Promote Cell Adhesion and
Spreading. Cellular viability of rMSCs seeded on tenascin-C
mimetic peptide nanofibers was assessed by calcein AM
staining, by comparison to cells that were cultured on a bare
glass surface and epitope-free peptide nanofibers at varying time
points (24, 48, and 72 h). Although a lower viability was
observed on TN-C mimetic PA scaffold at early time points,
cells adapted to the surface after 48 h. MSCs are multipotent
cells that are known to present a nonhomogeneous cell
population. Although the cells that we used were previously
selected to express certain MSC markers (Invitrogen), cultured
MSCs display variable phenotypes like proliferation capacity
and viability as well as giving different response to differ-
entiation stimuli. The plastic properties of MSCs can also
contribute to heterogeneity of MSC cultures.31 Cellular
heterogeneity within the population can be caused by persistent
cell individuality coming from fluctuations of protein levels,
which induce nongenetic cell individuality.32 Heterogeneity of
MSC cultures may be the reason for differences in viability of
our cells on tenascin-C mimetic scaffold at different time
points. Although a group of the cells died up to 48 h, viability of
the cells on all surfaces was comparable at the end of 72 h with
no significant differences between groups (Figure 3). This
indicates that this bioactive material is causing differential
effects on different cell groups. SEM images of cells seeded on
the scaffold revealed that rMSCs spread and attained their
different morphologies on all of the surfaces on day 7 and 12
(Figure 4). These results indicated that tenascin-C mimetic
peptide nanofibers provide attachment and spreading of
rMSCs. Also, SEM images indicated that rMSCs on tenascin-
C mimetic scaffold display a characteristic morphology that is
different from that of the cells seeded on control peptide
nanofibers and bare surfaces, possibly due to the effect of 2D
microenvironment on differentiation process.
3.3. Peptide Nanofibers Enhance Gene Expressions of
Osteogenic Markers. To understand whether the morpho-
logical change of rMSCs on tenascin-C mimetic scaffold is
caused by osteogenic differentiation, gene expression profiles of
cells cultured on peptide network coated and bare surfaces were
analyzed. First, expression of MSC markers including CD44
and CD90 were studied to verify the differentiation of MSCs.
Although decrease in CD44 expression is not significant,
decrease in CD90 was found to be statistically significant,
confirming the loss of MSC characteristics of the cells (Figure
5a). In order to check the effect of biologically active peptide
nanofiber systems on the progression of osteogenic differ-
entiation of rMSCs at mRNA level, expression of osteogenic
markers including Runx2, osteopontin, and collagen I was
examined with Sox9 on day 12 (Figure 5b). Although Sox9 is
the best-known master regulator for chondrocyte differentiation
and cartilage formation,33 it is specifically expressed in the
osteogenic cell compartments together with osteogenic markers
such as Runx2, collagen I, and osteopontin.34 Expressions of
Sox9 and Runx2 genes, early markers of ostegenic differ-
entiation, were upregulated by ∼2.0- and 1.6-fold, respectively,
when rMSCs were cultured on TC-PA/E-PA compared with
cells on K-PA/E-PA and TCP surfaces. Osteopontin is a
secreted adhesive glycoprotein detected within bone extrac-
ellular matrix. Osteopontin expression of the cells on TN-C
mimetic scaffold was also increased, by about 3-fold. Collagen I
is an important component of bone extracellular matrix, which
interacts with cell surface integrins and other ECM proteins.
This protein plays an important role in cell adhesion,
proliferation, and differentiation of the osteoblast phenotype.
In parallel to osteopontin expression, collagen I expression was
also significantly upregulated in cells cultured on TC-PA/E-PA
scaffold (4.5- and 1.9-fold increase when compared with K-PA/
E-PA and TCP, respectively). These significant differences in
Figure 3. Viability of rMSCs when cultured on peptide nanofibers and
TCP analyzed by calcein ethidium homodimer live−dead assay. This
assay showed that rMSCs adapted to PA scaffolds and have
comparable viability with bare surface at the end of 72 h.
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the mRNA expression of ostegenic markers between the cells
seeded on the tenascin-C mimetic peptide nanofiber scaffold
and epitope free scaffold, as well as bare surface, were
considered as evidence of osteogenic differentiation. It is
widely known that MSCs have capacity to differentiate into a
variety of cell types. Therefore, to be sure that the differentiated
cells we observed belong to osteogenic lineage and not other
cell types, we analyzed expression of specific markers of other
common cell types that MSCs can differentiate. Collagen II
expression was analyzed for chondrogenic differentiation along
with Pax7 for myogenic differentiation, FSP for fibroblast
differentiation, βIII-tubulin, NFL, and SYN1 for neural
differentiation, and MBP, BLBP, and Pax6 for astroglial
differentiation (Figure S5, Supporting Information). There
was no detectable up-regulation in these markers indicating that
rMSCs underwent osteogenic lineage commitment.
3.4. Peptide Nanofibers Stimulate Alkaline Phospha-
tase Activity and Mineralization. The osteoblasts are the
differentiated bone-forming cells responsible for secreting
collagen−proteoglycan matrix and calcification of bone matrix.
When MSCs undergo osteogenic differentiation, they express
osteoblast markers. MSCs undergo osteogenic differentiation in
a progressive manner.35 The early phase of in vitro osteogenic
differentiation can be characterized by the expression of alkaline
phosphatase (ALP) at mRNA and protein level.36 After the
initial peak of ALP expression, its level starts to decrease. Late
stage of osteogenic differentiation results in elevated expression
of osteopontin, followed by calcium and phosphate deposi-
tion.35,37 Thus, early phase of osteogenic differentiation was
analyzed with ALP assay, and the amount of calcium deposition
was assayed with alizarin red staining for detection of late phase
differentiation. Compared with epitope free scaffold and bare
surface, ALP activity of rMSCs on TN-C mimetic scaffold was
increased significantly by about 2-fold on day 3. Although, ALP
activity of rMSCs on biologically active scaffold displayed lower
ALP activity on day 7 compared with that on day 3, ALP
Figure 4. PA substrates are biocompatible and support adhesion of rMSCs. SEM images of rMSCs cultured on TC-PA/E-PA, E-PA/K-PA gels, and
TCP at 7 days and 12 days after cell seeding. Scale bars are 100 μm.
Figure 5. Gene expression analysis of (a) MSC markers and (b) osteogenic markers. The expression level of each gene was normalized against TCP
and GAPDH was used as the internal control. Values represent mean ± SEM (***p < 0.001, **p < 0.01, *p < 0.05).
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activity of cells on bioactive surface still remained higher than
those on epitope free scaffold and TCP (Figure 6a). In order to
test the mineral deposition of rMSCs as a late marker of
osteogenic differention, alizarin red staining was performed on
day 7 and day 12, and calcium deposition was quantified by
extracting alizarin red bound calcium from the surface followed
by a colorimetric measurement. The results indicated that
calcium deposition on TC-PA/E-PA was significantly higher
compared with that on K-PA/E-PA surface and bare surface on
day 12. Similar mineral deposition pattern was also observed on
day 7 (Figure 6b,c).
The differentiation of MSCs in vitro largely depends on the
culture conditions. Osteogenic differentiation of MSCs is
generally induced by the presence of dexamethasone, ascorbic
acid, and β-glycerol phosphate.4 However, TN-C mimetic
peptide scaffold can induce osteogenic differentiation despite
the absence of these constituents or supplemental osteogenic
growth factors. TN-C derived bioactive epitope acted as the
sole triggering factor for osteogenic commitment of MSCs,
since ALP activity, calcium deposition, and expression of
osteogenic marker genes were higher on TN-C mimetic
peptide nanofibers compared with epitope free control peptide
nanofibers and bare surface. Although the presence of a stiff
environment is also known to be an important requirement for
induction of osteogenic differentiation,9−11 bioactivity caused
by TN-C derived peptide sequence is more effective than the
requirement of high modulus to induce osteogenic differ-
entiation. Therefore, bioactivity introduced by our PA scaffold
is the only factor to induce osteogenic differentiation
compensating for the lack of osteogenic supplements in the
medium and rigidity of the substrate.
4. CONCLUSION
Bone tissue regeneration is essential for the treatment of large
bone defects. Alternative to the current treatments, which have
several drawbacks including infection, chronic pain, and
stiffness, using biomaterial scaffolds that can mimic the
microenvironment of osteogenic cells has become highly
promising for clinical therapy in recent years since these
biomaterials can provide key bioactive signals to create a
synthetic microenvironment to control cell fate. In this study,
we presented that a single bioactive epitope, TN-C mimetic
peptide, enables MSCs to (1) attach and adapt to the bioactive
gel, (2) go through a morphological change that is supported
with a change in the gene expression profile as a sign of
differentiation, (3) display increased ALP activity, and (4)
deposit calcium and form a mineralized matrix. The results
show that the extracellular mimetic approach used here allows
MSCs to undergo the osteogenic differentiation pathway
without any additional factors including growth factor and
medium supplements and regardless of suitable mechanical
properties normally required for osteogenic differentiation.
Overall, our results showed that incorporation of tenascin-C
derived bioactive epitope into a self-assembled peptide
amphiphile nanofiber system constitutes a promising platform




LC-MS measurements, phase contrast image of rMSCs, gene
expression levels of different differentiation markers, and primer
list used for qRT-PCR expression analysis. This material is
available free of charge via the Internet at http://pubs.acs.org.
Figure 6. Effect of PA nanofibers on osteogenic activity. (a) ALP activity of rMSCs on day 3 and 7. (b) Quantification of relative calcium deposition
on day 7 and 12. (c) Deposition of calcium on peptide coated substrates and TCP on day 7 and 12 as demonstrated by alizarin red staining; ***p <
0.001, **p < 0.01.
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